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Abstract
The mainstay of tuberculosis diagnosis in cattle and deer has been the tuberculin skin test. Recent advances have allowed the
incorporation of blood based assays to the diagnostic arsenal for both cattle and deer. Use of defined and specific antigens has
allowed for improved specificity of cell mediated assays in both cattle and deer and advances in antibody tests for tuberculosis
have potential for use in free-ranging and captive cervid populations. Combined use of blood-based assays with skin testing will
require further understanding of the effect of skin testing on the accuracy of blood based assays. Models of experimental
infection of cattle have allowed for increased understanding of natural disease pathogenesis. Differences likely exist; however,
between cattle and deer in both disease distribution and primary route of inoculation in naturally infected animals.
Published by Elsevier B.V.
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1. Issues related to diagnosis—advances since
the Mycobacterium bovis 2000 conference
A workshop of the M. bovis 2000 conference on
immunodiagnosis concluded that in vitro IFN-g-based
tests and improved antigens should be evaluated for
use in TB eradication campaigns. At that time,
antibody-based tests for cattle were lacking sensitivity,
yet development of improved platforms and antigens
was encouraged. It was acknowledged that antibody-
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based tests are useful for diagnosis of tuberculous
deer.
Since the last conference, the IFN-g assay has been
widely adapted as a field test for bovine TB in multiple
countries, either as a follow-up to or in parallel with
tuberculin skin testing. Large scale field trials of the
IFN-g assay in Australia in the early 1990’s indicate
that the sensitivity/specificity of the assay are 93.6/
96.3%, respectively (Wood et al., 1992). Additional
studies indicate that the sensitivity of the assay ranges
from 81.8 to 100% and the specificity from 94 to 100%
(reviewed by Wood and Jones, 2001). In areas
where TB prevalence is low, concern exists that the
specificity of the IFN-g assay, using standard
PPD antigens, is insufficient for program needs.
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For example, officials in Michigan, USA initiated
IFN-g testing as a follow-up to tuberculin skin testing
in 2004, with 2332 tests conducted during that year.
Test performance is monitored separately in two zones
within Michigan (i.e., locales based on TB prevalence). In 2004, test specificity was significantly
greater in the TB endemic zone (96.9%) compared to
the TB disease-free zone (90.8%) (Larry Judge,
USDA, APHIS, personal communication). The unexpected lower specificity in the TB-free zone limits the
use of the test in such areas due to higher than desired
indemnity costs. To overcome this problem a
validation study has been implemented in Michigan
to evaluate the use of rESAT-6/CFP-10 for improving
test specificity. Possibly, use of specific antigens will
improve the specificity of the test and prove useful in
areas of low TB prevalence.
Application of antibody-based tests has been
extended to use with TB surveillance of free-ranging
white-tailed deer in Michigan. Two advances have
made this possible. First, a capture and release strategy
in the TB endemic area was proven feasible. It was
determined that a reasonable percentage of freeranging deer could be captured, bled, and radiocollared with minimal injuries. Secondly, antibodybased tests performed satisfactorily for TB surveillance of free-ranging white-tailed deer using blood
samples collected by hunters. Antibody-based tests
are particularly appealing for surveillance of captured
free-ranging populations as test formats amenable to
animal-side evaluation are now available. Additionally, serum can be stored for later analysis without
need for immediate processing. This allows batch
processing, application of confirmatory tests, option
for allotment to multiple laboratories, and archiving
for future tests. Antibody-based tests are also being
evaluated for use in TB surveillance of free-ranging
Eurasian badgers (Meles meles) in the UK and elk
(Cervus elaphus nelsoni) in Canada. Similar applications may prove useful for other free-ranging
populations (e.g., cape buffalo, lions, and elephants).
Application of skin testing and slaughter surveillance procedures has greatly reduced TB prevalence in
countries with active eradication campaigns. Despite
successes, new diagnostic challenges resulting from
very low prevalence of disease and new wildlife
reservoirs have resulted in the need for development
and application of additional or improved tests. As

vaccination schemes are implemented, tests to distinguish vaccinated from infected animals will also be
required. The focus of this section on diagnosis is to
highlight advances over the past 5 years and identify
new applications for TB tests of cattle and wildlife.

2. Host response
The host response to the tubercle bacillus is
complex and broad, involving all aspects of the
immune system (Flynn and Chan, 2001; Kaufmann,
2001). The organism has evolved to avoid immune
clearance and induce chronic lesions ensuring
transmission by infectious aerosol droplets (North
and Jung, 2004). Paradoxically, lesions (i.e., granulomas) are elicited as a mechanism to limit spread of
the bacillus, thereby preventing early demise of the
host. This complex host/pathogen interplay affords
both diagnostic challenges and opportunities.
Robust delayed type hypersensitivity (DTH) and
IFN-g responses are elicited upon experimental and
natural infection with M. bovis. The bias of the
immune response to M. bovis is a T helper type-1
response as evidenced by IFN-g, interleukin (IL)-12,
and tumor necrosis factor (TNF)-a production to
pathogen-associated antigen and exacerbation of
disease when these cytokine pathways are disrupted
(e.g., genetic deficiencies or inhibitory therapies)
(Flynn, 2004). Thus, a mainstay for TB diagnosis is
evaluation of these cell-mediated responses either by
skin test (Monaghan et al., 1994) or IFN-g-based
assays (Wood and Jones, 2001). Mycobacterial
infections also induce antibody responses. In general,
specific antibody responses are most easily detected
late in disease and correlate with severe progression of
disease (Plackett et al., 1989). With improving
technologies, the current dogma of early cell-mediated
and late humoral responses to mycobacterial infections may be challenged (Koets et al., 2001). Indeed,
intratonsilar inoculation of cattle with Mycobacterium
avium subsp. avium, M. avium subsp. paratuberculosis, Mycobacterium kansasii, or M. bovis induces an
antibody response detectable within 2–4 months of
inoculation; however, the intratonsilar route may favor
early antigen/B cell interactions facilitating production of specific antibody (Waters et al., 2003, 2004a;
Waters et al., Unpublished observations).
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3. Complex versus specific antigens
Over the past century, the predominant antigens
used for TB diagnosis have been complex, ill-defined
whole cell lysates and culture filtrates, particularly
tuberculin. Complex preparations provide a wide array
of antigens for presentation to lymphocytes and are
representative of the range of antigens presented to the
host upon infection. The most widely used antigen for
diagnosis of tuberculous cattle is purified protein
derivative (PPD) prepared from heat-killed cultures of
mycobacteria. PPD provides excellent sensitivity for
diagnostic tests yet lacks specificity due to epitopes
shared by various mycobacteria and other closely
related bacteria. Either in vivo (skin test) or in vitro
(IFN-g) comparisons made between responses to M.
bovis derived PPD and M. avium derived PPD are
beneficial for differentially diagnosing responses to
the respective mycobacteria. Improved specificity
may be obtained through use of defined antigens. Of
particular relevance for cattle are antigens that can be
used to distinguish between M. bovis and M. avium
infection. Other mycobacterial species commonly
isolated from cattle within the USA include:
Mycobacterium kansasii, Mycobacterium fortuitum,
Mycobacterium smegmatis, Mycobacterium pulveris,
Mycobacterium gadium, Mycobacterium terrae complex, and Mycobacterium duvalii (Beth Harris,
personal communication). Responses generated by
exposure to non-tuberculous mycobacteria and other
related non-mycobacterial species might be of greater
significance for diagnostic tests used with cervids. A
prime example is reindeer (Rangifer tarandus) that are
notably prone to cross reactive responses that interfere
with TB test interpretation using standard PPD
antigens.
ESAT-6 and CFP-10 are potent IFN-g-inducing
antigens of tuberculous mycobacteria. These two
proteins are co-secreted and form a tight 1:1 complex
upon export (Renshaw et al., 2002). Genes for ESAT-6
and CFP-10 are absent in many environmental, nontuberculous mycobacteria as well as in the TB vaccine
strain, M. bovis BCG. Use of ESAT-6 and/or CFP-10
as antigens in IFN-g-based TB assays enhances
specificity when compared to use of M. bovis PPD
(Pollock and Andersen, 1997; Pollock et al., 2000;
Vordermeier et al., 2001; Buddle et al., 2001, 2003).
Unfortunately, genes for EAST-6 and CFP-10 are
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present in some non-tuberculous mycobacteria, most
notably M. kansasii, M. marinum, M. leprae, and M.
smegmatis (Gey Van Pittius et al., 2001, 2002; Geluk
et al., 2002, 2004). Experimental infection of cattle
with M. bovis, M. avium subsp. avium, M. avium
subsp. paratuberculosis, or M. kansasii has demonstrated that a fusion protein of ESAT-6 and CFP-10 is
recognized by M. bovis and M. kansasii-infected cattle
but not by cattle infected with either of the two M.
avium strains (Waters et al., 2004a; Waters et al.,
Unpublished observations). ESAT-6 has also been
used to discriminate between cattle naturally infected
with M. bovis and cattle sensitized/infected with
environmental, non-tuberculous strains of mycobacteria or vaccinated for paratuberculosis (Pollock and
Andersen, 1997; Buddle et al., 2003). In Ireland
studies have demonstrated the potential for ESAT-6 as
a skin test antigen; however, large quantities of antigen
(up to 400 mg) and extended time to reading (i.e., 5
days instead of 3 days for standard antigens) are
required for best results (Pollock et al., 2003). It
should be noted that these potential pitfalls might be
overcome with use of adjuvants or additional specific
antigens.
A relatively large number of M. tuberculosis
complex-specific antigens were discovered and
characterized in the late 1990s. Clearly, ESAT-6 and
CFP-10 are leading candidates for improved antigens
for use with cellular-based assays. Recently, Vordermeier et al. (2004) demonstrated that use of a fusion
protein of ESAT-6, CFP10, and detoxified Bordetella
pertussis adenylate cyclase improves the frequency of
responding cells in an IFN-g assay. Other antigens
such as Ag85, MPB83, MPB64, MPB70, Phos1
(38 kDa antigen), and somatic stress proteins have
been evaluated for use in cellular based assays with
variable success (Fifis et al., 1994; Vordermeier et al.,
1999; Rhodes et al., 2000; Pollock et al., 2001; Buddle
et al., 2003). Recent advances in whole genome
sequencing of M. bovis (Garnier et al., 2003) and
related mycobacteria (e.g., M. avium subsp. avium and
M. avium subsp. paratuberculosis) have resulted in
identification of numerous additional putative antigenic targets. Use of antigen cocktails and fusion
proteins may be employed to enhance the sensitivity
of specific antigen based tests. For instance, Lyashchenko et al. (2000) developed an antibody-based test
using complex and defined antigens. This test (multi-
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antigen print immunoassay or MAPIA) is useful for
screening responses by various host species to
determine antigen recognition patterns and kinetics
of responses to various antigens during the course of
infection and even in response to antibiotic therapy.
Optimal antigens as defined by MAPIA are then used
in a lateral flow immunoassay format or ‘‘Rapid Test’’
(Greenwald et al., 2003). The Rapid Test is easy to use,
amenable to animal side testing, adaptable for multispecies use, and results are obtained within 15 min.
This strategy has proven promising for use in various
species including white-tailed deer, Eurasian badgers,
cattle, and various zoo species (Greenwald et al.,
2003; Lyashchenko et al., 2004; Waters et al., 2004b;
Lyashchenko, personal communication). As with
MAPIA and Rapid Test, future diagnostics including
cell- and antibody-based tests will likely employ the
use of complex antigens for test sensitivity and defined
antigens for test specificity.

(Buddle et al., 1995; Doherty et al., 1995; Rothel et al.,
1992; Gormley et al., 2004). Ryan et al. (2000)
determined that the IFN-g test is reliable when applied
8–28 days after skin testing; however, responses at
these time points were not compared to pre-skin test
responses. Rothel et al. (1992) found a marked decline
in the IFN-g response to M. bovis PPD at 7 days after
skin test; however, this decline was followed by an
enhanced response. Using M. bovis sensitized cattle,
Whipple et al. (2001) found that PPD specific IFN-g
responses were boosted 7 days after skin test. Injection
of M. bovis PPD for the caudal fold test in 19
experimentally infected calves resulted in slightly
boosted IFN-g responses 3–5 days after injection and
responses from 7 to 55 days later that were similar to
pre-skin test values (Palmer et al., Unpublished
observations).

5. Issues related to pathogenesis
4. Effects of skin test on cell- and antibodybased assays
Injection of PPD for skin testing elicits a temporary
suppression of in vivo responsiveness to mycobacterial antigens that may confound interpretation of
subsequent tests (Lepper et al., 1977; Radunz and
Lepper, 1985; Thom et al., 2004). Such suppression is
present from 4 to 60 days after injection (Radunz and
Lepper, 1985; Doherty et al., 1995). Mechanisms
underlying this reduced responsiveness are unclear;
however, both cellular and humoral factors have been
proposed. Practically, this phenomenon limits the
versatility of skin testing and is a forewarning of the
impact of antigen administration on subsequent in
vitro-based testing.
As with DTH responses, lymphocyte proliferative
responses are suppressed immediately following
injection of PPD in M. bovis-infected or sensitized
cattle (Doherty et al., 1995; Hall and Thoen, 1983). In
contrast, antibody responses are enhanced by PPD
injection, with peak effects 2 weeks after injection
(Lyashchenko et al., 2004). Effects of skin testing on
the M. bovis-specific IFN-g response, however,
remain unclear. Most studies indicate that IFN-g
responses are either not affected or slightly boosted
immediately after skin testing (i.e., 7–28 days later)

The pathogenesis of bovine tuberculosis is not as
well understood as the pathogenesis of tuberculosis in
humans. Advances in the field of human tuberculosis
have been made using various small animal models of
M. tuberculosis infection. Extrapolations of findings
from small animal models have been made to bovine
tuberculosis. Such extrapolations may not always be
appropriate as there are profound differences in host
susceptibility, host immune response, environment,
host ecology, and behavior. The current discussion
will deal primarily with studies in cattle and cervids.

6. Route of infection and lesion distribution
With some exceptions, it is agreed that cattle
become infected with M. bovis by either the oral or
respiratory routes (Neill et al., 1994). The oral route is
likely most important in calves nursing tuberculous
cows, while the respiratory route is most common in
cattle in general (Neill et al., 1994). In the late 1990’s,
surveys of tuberculous cattle in Great Britain (Phillips
et al., 2003) revealed that 67% of tuberculous lesions
were within the lungs and pulmonary lymph nodes
(tracheobronchial and mediastinal). Cranial lymph
node lesions were observed in 39%, while only 8% of
lesions involved mesenteric lymph nodes. Although
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many studies demonstrate a tendency toward lesion
development in pulmonary lymph nodes rather than in
lungs, meticulous examination often reveals lesions in
the lungs; most <1 cm in diameter (McIlroy et al.,
1986). Indeed, most studies of naturally infected cattle
describe the majority of lesions within the lung,
pulmonary lymph nodes and cranial lymph nodes
(Stamp, 1944; Lepper and Pearson, 1973). The
conclusion is that this distribution of lesions suggests
a respiratory route of infection. Investigations in
naturally infected cattle suggest that lesions of the
alimentary tract, although not common generally, are
more common in temperate climates where conditions
favor dissemination and survival of M. bovis on
forage, while respiratory tract lesions are more
common in arid climates where conditions favor
aerosolization of M. bovis (Lepper and Pearson,
1973).
In white-tailed deer and other cervids, lesion
distribution differs from that seen in cattle. In whitetailed deer, elk (Cervus elaphus nelsoni), and red deer
(Cervus elaphus) the preponderance of lesions occur
in the medial retropharyngeal lymph nodes (Beatson,
1985; Whiting and Tessaro, 1994; O’Brien et al.,
2001; Palmer et al., 2000). Similar to M. bovis
infection of humans, but unlike tuberculosis in cattle,
discharging sinus tracts have been associated with
cranial lymph node lesions in red deer (Mackintosh
and Griffin, 1994) and fallow deer (Dama dama)
(Robinson et al., 1989), but not white-tailed deer.
Tonsilar lesions are commonly seen in white-tailed
deer with tuberculous lesions of the medial retropharyngeal lymph nodes (Palmer et al., 2002b). In
ruminants, afferent lymphatics are not present in the
tonsil while efferent lymphatics drain from the tonsil
directly to the retropharyngeal lymph nodes. This
primary complex of tuberculous lesions involving the
tonsil and retropharyngeal lymph nodes is remarkably
similar to that seen in humans. Indeed, in humans
the primary complex resulting from oral exposure to
M. bovis through consumption of unpasteurized milk
consists of lesions in the tonsil and draining lymph
node (Ramsay, 1992; Samuelson and von Lichtenberg,
1994). This has led to the hypothesis that white-tailed
deer are generally infected with M. bovis through the
oral route. Supporting evidence exists in demonstrations of deer to deer transmission through sharing of
feed (Palmer et al., 2004b).
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In white-tailed deer, as well as other cervids, routes
of inoculation that mimic oral exposure may be more
relevant models of natural infection than those
simulating aerosol exposure. Models of natural
infection in red deer and white-tailed deer (Mackintosh et al., 1995; Palmer et al., 1999a) using
intratonsilar inoculation result in lesion distribution
similar to that seen in naturally infected deer (O’Brien
et al., 2001). Moreover, aerosol exposure of whitetailed deer to M. bovis did not result in lesion
distribution similar to that seen in most naturally
infected deer (Palmer et al., 2003).
It has been stated that the route of transmission of
M. bovis can be deduced by the pattern of lesions
observed in the infected animal (Biet et al., 2005).
However, such a determination may not be straightforward. A recent study in cattle showed that feeding
various doses of M. bovis resulted in lesions limited to
the lung, pulmonary lymph nodes and cranial lymph
nodes with no involvement of mesenteric lymph nodes
or abdominal viscera (Palmer et al., 2004a). Furthermore, M. bovis could not be isolated from mesenteric
lymph nodes or abdominal viscera by bacteriological
culture. In this same study, interspecies transmission
of M. bovis by sharing of feed between cattle and deer
did not result in lesions of the mesenteric lymph nodes
or abdominal viscera, but rather lesions of the lung,
pulmonary lymph nodes and cranial lymph nodes.
Critical to assessment of route of infection through
lesion distribution is the understanding of the primary
complex. The primary complex of tuberculosis is
considered to be the combination of lesions in the
initial focus of infection and the regional (i.e.
draining) lymph node. In cases of prolonged or severe
disseminated disease, determination of the primary
complex may be impossible, confusing speculation
concerning the initial route of infection. Moreover,
when infection occurs across mucous membranes such
as the pharynx or intestine, the initial lesion in the
mucous membrane may not be visible while lymph
node lesions are obvious (Dungworth, 1993).

7. Minimum infectious dose
The dose of M. bovis that cattle and deer are
exposed to in nature is unknown, but is likely highly
variable and repeated. The minimum infectious dose is
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highly dependent on the route of infection. In
numerous studies in guinea pigs reviewed by
Sigurdson (1945) infection through the oral route
required doses orders of magnitude greater than that
required for infection via aerosol. In fact, doses as low
as 1–5 bacilli resulted in infection via aerosol, while
10–20 million bacilli were required to infect via the
oral route.
There is great variation in the reported minimum
infectious dose for cattle. Variations are due to
differences in individual animals, host species,
bacterial strain and route of inoculation. Studies
reviewed by Francis (1947) showed that doses of 106–
107 CFU were required to infect cattle or sheep
through the oral route, while as few as 1–5 bacilli
could infect via the aerosol route. Studies in cattle
cited by Griffin and Dolan (1995) report that 4  105
bacilli are required for infection via the respiratory
route and 1000 times more bacilli are required for
infection through the oral route. Recent investigations;
however, have shown that cattle can be infected orally
with as few as 5000 CFU of M. bovis administered in
the feed (Palmer et al., 2004a). Conversely, mathematical modeling of M. bovis excretion by tuberculous
cattle suggests that a single bacillus may be sufficient
to cause infection by the aerosol route (Neill et al.,
1991).

8. Natural versus experimental infection
To simulate natural disease, experimental infection
of cattle with M. bovis has been done by intranasal
(Cassidy et al., 1998, 1999), intratracheal (Buddle
et al., 1994) and intratonsilar routes (Palmer et al.,
1999b). Infections via the respiratory route in cattle
likely mimic natural infection more than other
methods of inoculation. However, there are various
means by which inoculum may be introduced into
the respiratory tract (e.g. intranasal, intratracheal,
aerosol). Intranasal administration of 104–105 CFU of
M. bovis reliably results in lesions in the lungs and
pulmonary lymph nodes. However, many other organs
are also involved suggesting development of generalized tuberculosis (Neill et al., 1988b). Moreover,
lesions are also commonly noted in the nasopharyngeal mucosa and trachea; sites not commonly
affected in naturally infected cattle. Intranasal doses of

103–105 CFU have been suggested to be too high to
simulate natural infection, resulting in atypical lesions
in the upper respiratory tract and exaggerated
involvement of the lungs (Phillips et al., 2003).
Intranasal administration of 92 CFU of M. bovis did
not result in lesion formation (Neill et al., 1988b).
Intratracheal inoculation of 500–800 CFU of
M. bovis results in lesions limited to the lungs and
pulmonary lymph nodes (Buddle et al., 1994 and
1995). Inoculation using higher doses (e.g., 5  105
CFU) results in widespread lesions suggestive of
generalized tuberculosis. Tracheal lesions, uncommon
in natural infection, can also result as an artifact of the
inoculation method.
Intratonsilar inoculation of cattle with 1  105
CFU of M. bovis results in consistent early lesion
formation in the medial retropharyngeal lymph nodes
(Palmer et al., 1999b) and later lesion development in
the lung and pulmonary lymph nodes (Palmer,
Unpublished results). Higher doses result in lesions
of generalized tuberculosis.
In aerosol exposure, the size of aerosolized droplets
carrying M. bovis is as important as the dose of
inoculum. The droplet nuclei mechanism of M.
tuberculosis infection in humans has shown that
residues, <5 mm, of evaporated droplets (droplet
nuclei) can be generated by talking or coughing.
Droplet nuclei remain airborne for prolonged periods
while larger droplets settle within short distances of
their source. Once inhaled, infectious droplet nuclei
reach the terminal bronchioles and alveoli, while
droplets >5 mm are removed in the upper respiratory
passages (Wells et al., 1948; Loudon and Roberts, 1967,
1968). Recent studies in cattle using aerosols containing M. bovis generated by a nebulizer have shown that
nebulization of 1000 CFU of M. bovis can result in
lesions similar to those seen in natural infection (Palmer
et al., 2002a). Lesions are limited to the lungs and
pulmonary lymph nodes with no lesions in cranial
lymph nodes, nasopharyngeal mucosa, or trachea.
Moreover, M. bovis could only be isolated by
bacteriological culture from the lungs and pulmonary
lymph nodes when doses of 1000 CFU were nebulized.
Direct and indirect contact exposure has been
successfully used to experimentally inoculate cattle
and deer. In many cases transmission rates have been
less than 100% with not all in-contact animals
developing tuberculosis (Neill et al., 1989; Palmer
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et al., 2004a), suggesting that the dose, although
difficult to control, is not overwhelming. Moreover,
the resulting distribution of lesions closely resembles
that seen in nature in both cattle and deer. White-tailed
deer, whether exposed to M. bovis directly through
shared housing (Palmer et al., 2001) or indirectly
through shared feed (Palmer et al., 2004b), develop
lesions similar to those seen in naturally infected deer
(O’Brien et al., 2001). The lack of dosage control;
however, limits the utility of such a model in situations
such as vaccine efficacy studies, where the assurance
of a standardized dosage is critical.

9. Shedding
In most countries with active bovine tuberculosis
control programs, infected herds contain few infected
animals. Currently, it is uncommon to find large
numbers of infected animals within a herd. This is due
in part to regular herd monitoring through skin testing.
The occurrence of low numbers of infected animals
within herds has also led to the belief that bovine
tuberculosis is characterized by low cattle to cattle
transmissibility with low numbers of M. bovis bacilli
shed by infected animals and a large infectious dose
required to initiate new infection in naı̈ve animals.
Accurate quantitative assessments of shedding of M.
bovis from infected cattle are difficult. In humans,
repeated sputum samples are evaluated before a
diagnosis is reached. In cattle, most investigations
have involved single time-point samples. In some
cases, M. bovis infection has been confirmed by
detailed postmortem examination, including bacteriologic culture (McIlroy et al., 1986), in others,
however, no such examination was conducted (De
Kantor and Roswurm, 1978). Estimates from such
studies suggest that 9–19% of infected cattle shed
M. bovis in nasal or tracheal secretions.
Experimental studies to examine shedding document latent periods between inoculation and initiation
of shedding. This latent period appears to be inversely
related to inoculum size. Cattle receiving 104 CFU of
M. bovis intranasally shed M. bovis in nasal mucus in
17.6 days, while cattle receiving 106 CFU intranasally
shed M. bovis in nasal mucus in 11 days (Neill et al.,
1988a). Once initiated, shedding is intermittent for up
to 38 weeks.
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Many investigators have categorized tuberculosis
in cattle as either open or closed. Open cases of
tuberculosis are those in which lesions, primarily in
the lung, allow excretion of M. bovis, while closed
cases are categorized by lesions that do not promote
excretion of bacilli. It is artificial to categorize cases as
open or closed, as many cases do not present with
obvious gross pulmonary lesions, yet contain small
lesions that are only detectable after meticulous
examination, including microscopic examination.
Careful examination revealed that 73% of bovine
cases with pulmonary lymph node lesions also had
lesions in the lungs (McIlroy et al., 1986). In 63% of
the cases only one lung lesion was present and 70% of
the lung lesions were <1 cm in diameter. The authors
conclude that all tuberculous cattle with lesions in the
pulmonary lymph nodes should be considered capable
of excretion of M. bovis. In a separate study of
tuberculin positive cattle, although all had gross
lesions of the pulmonary lymph nodes, only one
animal had gross lung lesions. M. bovis was found by
bacteriological culture; however, in 4 of the 25
animals, demonstrating that gross lung lesions are not
a prerequisite of bacillary shedding (Neill et al.,
1988a). Moreover, animals with no visible lesions are
not necessarily non-infected. M. bovis has been
isolated from skin-test negative animals with no gross
lesions (Neill et al., 1992). Meanwhile, as many as
10% of cattle with no visible lesions can be culture
positive for M. bovis (Corner, 1994).

10. Host species differences
Species differences in susceptibility to infection
with M. bovis are known to exist. Differences in lesion
distribution between cattle and cervids have been
discussed. However, differences among species of
Cervidae also exist. The most accurate comparisons
are made by inoculation of different species by similar
routes using similar dosages. Such a side by side
comparison has demonstrated that white-tailed deer
develop more widespread lesions than reindeer when
dosed intratonsilarly with 105 CFU of M. bovis
(Palmer et al., 2006). Intratonsilar inoculation of red
deer with similar doses of M. bovis results in infection
in 90% and lesions in 70% of inoculated animals
(Griffin and Mackintosh, 2000). This suggests that
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reindeer are similar to red deer in their susceptibility
and response to experimental infection with M. bovis
and that white-tailed deer may be more susceptible to
M. bovis than other species of deer.

11. Conclusion
Future research will likely focus on improving the
sensitivity and specificity of both cell-mediated and
humoral blood based assays for bovine tuberculosis.
The increasing importance of wildlife in the epidemiology of bovine tuberculosis will require continued
research on diagnosis and pathogenesis of M. bovis
infection in the various wildlife species. There are still
many unsolved problems associated with the pathogenesis and immune response to tuberculosis. The
variation of responses in a variety of susceptible hosts
makes the problem especially challenging. A broad,
multi-disciplinary approach in comparative pathology,
comparative immunology and molecular biology will
be required.
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